Document

SD 1 formsd-2021conflictminerals.htm SD Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM SD

Specialized Disclosure Report

Medtronic plc

(Exact name of Registrant as Specified in its Charter)

Ireland

1-36820

98-1183488

(State or other jurisdiction
of incorporation)

(Commission
File Number)

(IRS Employer
Identification No.)



20 On Hatch, Lower Hatch Street Dublin 2, Ireland						n/a
(Address of principal executive offices)						(Zip Code)



Karen Parkhill						763-514-4000

(Name and telephone number, including area code, of the person to contact in connection with this report.)

Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:


x			Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2021.

INFORMATION TO BE INCLUDED IN THE REPORT

Section 1 - Conflict Minerals Disclosure

Item 1.01 Conflict Minerals Disclosure and Report

This Form SD of Medtronic plc (the “Company”) is filed pursuant to Rule 13p-1 (the “Rule”) promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period from January 1, 2021 to December 31, 2021.

A copy of Company’s Conflict Minerals Report is provided as Exhibit 1.01 hereto and details the due diligence measures undertaken during the reporting period by the Company on a consolidated basis. A copy of the Conflict Minerals Report is also publicly available through the Company’s website: www.medtronic.com (under the “Our Company” caption and “Financials” subcaption).

Item 1.02 Exhibit

The Company has filed, as an exhibit to this Form SD, the Conflict Minerals Report of the Company required by Item 1.01.

Section 2 - Exhibits

Item 2.01 Exhibits

The following exhibit is filed as part of this report:

Exhibit 1.01 - Conflict Minerals Report of the Company

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.


		Medtronic plc

Date: May 31, 2022	By	/s/ Karen L. Parkhill
		Karen L. Parkhill
		Executive Vice President and Chief Financial Officer

EXHIBIT INDEX

Medtronic plc

Form SD



Exhibit No.						Description

1.01						Conflict Minerals Report of the Company